Fraunhofer ITEM belongs to Europe’s largest application-oriented research organization, the Fraunhofer-Gesellschaft. Its scientists have spent over 35 years studying the toxicology of airborne substances, generating a wealth of information on respiratory diseases (allergic rhinitis, bronchial asthma, COPD, and others) in the process. Where inflammatory and allergic diseases of the airways are concerned, the institute possesses extensive R&D expertise on everything from the molecular level to conducting clinical trials.
Its GMP unit is also able to manufacture investigational biopharmaceutical products in compliance with the German Drug Act.
Our GMP, toxicology, preclinical, and clinical research experts cover the entire pharmaceutical development chain under one roof.
The Hannover Medical School (Medizinische Hochschule Hannover, or “MHH” for short) is one of Germany’s leading university medical centers. It is renowned for its excellent patient care, research, and teaching. Each year, more than 54,000 inpatients and 310,000 outpatients receive a wide range of top-quality treatment and care.
The medical research performed at MHH also makes extensive use of the latest diagnostic procedures and therapies.
MHH conducts several hundred clinical studies per year on a variety of indications, a large share of which are investigator-initiated trials. The MHH CRC Core Facility with its team of experienced investigators and clinical trial nurses for early-phase and proof-of-concept studies is located in very close proximity to 18 medical centers and 75 MHH departments.
The Helmholtz Centre for Infection Research in Braunschweig, Germany, studies the mechanisms involved in infectious diseases and the body’s defenses against these. Scientists of its epidemiology department are currently laboring to determine the extent to which previously neglected factors affect the risk of catching infectious diseases or developing immune system disorders.
The results of this research will ultimately be used to systematically support efforts to design a better healthcare system in Germany and improve public health. To this end, HZI and MHH initiated a collaboration already at an earlier stage, establishing a center for experimental and clinical infection research (TWINCORE) that combines basic research and clinical development.